Harvesting small trees and forest residues

Eight countries collaborated and shared technical information on the harvesting of small trees and forest residues in a three year program. Proceedings and reports from workshops and reviews are summarized in a review of activities and harvesting systems of the participating countries. Four databases were developed for harvesting and transportation of these materials.     

Electric arcing burn hazards

The paper presents recent results in the area of high-power testing aimed at improving the safety of electrical staff working on live equipment. The driver for this work is the American Guide (IEEE 1584) on such exposure hazards, which has the potential for international adoption and, in the authors' opinion, does not provide a suitable methodology for assessing the hazard. A selection of results is presented, obtained in a high-power-system-supplied commercial test laboratory, using the latest charge-coupled device (CCD)-based high-speed video-recording methods. Results are reported for 415-V currents in the range of 1000-70 000 prospective root mean square (rms) amperes and for tests at 5000 V in the range of 1000-27 000 A. The impact of conventional protective devices is included together with some disturbing video results for circuit-breaker-protected systems. The major part of the material in this paper was first presented at the 7th International Conference on Electric Fuses and Their Applications, Jurata, Poland, in 2003.     

EFFECT OF THE RATIO Th/U ON TL DATING ACCURACY

ＥＦＦＥＣＴＯＦＴＨＥＲＡＴＩＯＴｈ／ＵＯＮＴＬＤＡＴＩＮＧＡＣＣＵＲＡＣＹ￥Ｐ．Ｌ．Ｌｅｕｎｇ（梁宝鎏）；ＭｉｃｈａｅｌＪ．Ｓｔｏｋｅｓ（ＤｅｐａｒｔｍｅｎｔｏｆＰｈｙｓｉｃｓａｎｄＭａｔｅｒｉａｌｓＳｃｉｅｎｃｅ，ＣｉｔｙＰｏｌｙｔｅｃｈｎｉｃｏ...     

BID: a novel BH3 domain-only death agonist

The BCL-2 family of proteins consists of both antagonists (e.g., BCL-2) and agonists (e.g., BAX) that regulate apoptosis and compete through dimerization. The BH1 and BH2 domains of BCL-2 are required to heterodimerize with BAX and to repress cell death; conversely, the BH3 domain of BAX is required to heterodimerize with BCL-2 and to promote cell death. To extend this pathway, we used interactive cloning to identify Bid, which encodes a novel death agonist that heterodimerizes with either agonists (BAX) or antagonists (BCL-2). BID possesses only the BH3 domain, lacks a carboxy-terminal signal-anchor segment, and is found in both cytosolic and membrane locations. BID counters the protective effect of BCL-2. Moreover, expression of BID, without another death stimulus, induces ICE-like proteases and apoptosis. Mutagenesis revealed that an intact BH3 domain of BID was required to bind the BH1 domain of either BCL-2 or BAX. A BH3 mutant of BID that still heterodimerized with BCL-2 failed to promote apoptosis, dissociating these activities. In contrast, the only BID BH3 mutant that retained death promoting activity interacted with BAX, but not BCL-2. This BH3-only molecule supports BH3 as a death domain and favors a model in which BID represents a death ligand for the membrane-bound receptor BAX.     

Early and intensive physiotherapy accelerates recovery postarthroscopic meniscectomy: results of a randomized controlled study

The efficacy of an early, intensive, supervised rehabilitation program to accelerate knee strength recovery in the first 3 weeks postmeniscectomy by arthroscopy was evaluated using a randomized controlled trial design. The maximal voluntary isokinetic strength of 31 men, randomly allocated to either a treatment (EXP) or a control (CTL) group, was measured twice by a blind rater: preoperatively (pretest) and 3 weeks postsurgery (posttest), using a computer-controlled Kin-Com dynamometer (Chattecx Corporation, Chattanooga, TN). Strength deficits of the operated leg at the pretest and posttest were established in percent of the values obtained for the sound leg at the pretest. In the interval between the surgery and the posttest, the patients of the EXP group (n = 15) received nine supervised treatments combined to home exercises whereas patients of the control group (n = 16) had no specific physiotherapy treatment but were given instructions in postsurgical management and prescribed exercises by the orthopedic surgeons. Patients of the EXP group had better knee extensor strength recovery than patients of the CTL group (ANCOVA, p < 0.001). The size of the strength difference (3 weeks postsurgery) between EXP and CTL subgroups (n = 8) matched according to preoperative deficits was as large as 26% and the residual deficits of the untreated patients were two to three times larger than those of the treated patients. The results of this study highlight the importance of instituting an early intensive and supervised rehabilitation program, especially for workers returning to a strenuous job requiring good knee extensor muscle function.     

CTLA4 mediates antigen-specific apoptosis of human T cells

The regulation of T cell-mediated immune responses requires a balance between amplification and generation of effector function and subsequent selective termination by clonal deletion. Although apoptosis of previously activated T cells can be induced by signaling of the tumor necrosis factor receptor family, these molecules do not appear to regulate T-cell clonal deletion in an antigen-specific fashion. We demonstrate that cross-linking of the inducible T-cell surface molecule CTLA4 can mediate apoptosis of previously activated human T lymphocytes. This function appears to be antigen-restricted, since a concomitant signal T-cell receptor signal is required. Regulation of this pathway may provide a novel therapeutic strategy to delete antigen-specific activated T cells.